Connection

Zdzislaw Szulc to Animals

This is a "connection" page, showing publications Zdzislaw Szulc has written about Animals.
Connection Strength

0.260
  1. Mechanistic insights into ceramidase inhibitor LCL521-enhanced tumor cell killing by photodynamic and thermal ablation therapies. Photochem Photobiol Sci. 2020 Sep 09; 19(9):1145-1151.
    View in: PubMed
    Score: 0.052
  2. Crosstalk between pro-survival sphingolipid metabolism and complement signaling induces inflammasome-mediated tumor metastasis. Cell Rep. 2022 12 06; 41(10):111742.
    View in: PubMed
    Score: 0.015
  3. Inhibition of acid ceramidase regulates MHC class II antigen presentation and suppression of autoimmune arthritis. Cytokine. 2020 11; 135:155219.
    View in: PubMed
    Score: 0.013
  4. Receptor-interacting Ser/Thr kinase 1 (RIPK1) and myosin IIA-dependent ceramidosomes form membrane pores that mediate blebbing and necroptosis. J Biol Chem. 2019 01 11; 294(2):502-519.
    View in: PubMed
    Score: 0.012
  5. Blocking Myristoylation of Src Inhibits Its Kinase Activity and Suppresses Prostate Cancer Progression. Cancer Res. 2017 12 15; 77(24):6950-6962.
    View in: PubMed
    Score: 0.011
  6. HPV/E7 induces chemotherapy-mediated tumor suppression by ceramide-dependent mitophagy. EMBO Mol Med. 2017 08; 9(8):1030-1051.
    View in: PubMed
    Score: 0.011
  7. Targeting FLT3-ITD signaling mediates ceramide-dependent mitophagy and attenuates drug resistance in AML. Blood. 2016 10 13; 128(15):1944-1958.
    View in: PubMed
    Score: 0.010
  8. Interaction of acid ceramidase inhibitor LCL521 with tumor response to photodynamic therapy and photodynamic therapy-generated vaccine. Int J Cancer. 2016 09 15; 139(6):1372-8.
    View in: PubMed
    Score: 0.010
  9. Ceramide channel: Structural basis for selective membrane targeting. Chem Phys Lipids. 2016 Jan; 194:110-116.
    View in: PubMed
    Score: 0.009
  10. 2'-hydroxy C16-ceramide induces apoptosis-associated proteomic changes in C6 glioma cells. J Proteome Res. 2013 Oct 04; 12(10):4366-75.
    View in: PubMed
    Score: 0.008
  11. Cationic ceramides and analogues, LCL30 and LCL85, as adjuvants to photodynamic therapy of tumors. J Photochem Photobiol B. 2013 Sep 05; 126:72-7.
    View in: PubMed
    Score: 0.008
  12. Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis. EMBO Mol Med. 2013 01; 5(1):105-21.
    View in: PubMed
    Score: 0.008
  13. LCL124, a cationic analog of ceramide, selectively induces pancreatic cancer cell death by accumulating in mitochondria. J Pharmacol Exp Ther. 2013 Jan; 344(1):167-78.
    View in: PubMed
    Score: 0.008
  14. L- threo -C6-pyridinium-ceramide bromide, a novel cationic ceramide, induces NADPH oxidase activation, mitochondrial dysfunction and loss in cell viability in INS 832/13 ?-cells. Cell Physiol Biochem. 2012; 30(4):1051-8.
    View in: PubMed
    Score: 0.008
  15. Bax and Bcl-xL exert their regulation on different sites of the ceramide channel. Biochem J. 2012 Jul 01; 445(1):81-91.
    View in: PubMed
    Score: 0.007
  16. Identification of C(6) -ceramide-interacting proteins in D6P2T Schwannoma cells. Proteomics. 2012 Jul; 12(13):2179-84.
    View in: PubMed
    Score: 0.007
  17. Ceramide channels: influence of molecular structure on channel formation in membranes. Biochim Biophys Acta. 2012 May; 1818(5):1291-301.
    View in: PubMed
    Score: 0.007
  18. IRF8 regulates acid ceramidase expression to mediate apoptosis and suppresses myelogeneous leukemia. Cancer Res. 2011 Apr 15; 71(8):2882-91.
    View in: PubMed
    Score: 0.007
  19. Purification and characterization of a second type of neutral ceramidase from rat brain: a second more hydrophobic form of rat brain ceramidase. Biochim Biophys Acta. 2011 Apr; 1811(4):242-52.
    View in: PubMed
    Score: 0.007
  20. Sphingolipid analysis by high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). Adv Exp Med Biol. 2010; 688:46-59.
    View in: PubMed
    Score: 0.006
  21. Anti-ceramidase LCL385 acutely reduces BCL-2 expression in the hippocampus but is not associated with an increase of learned helplessness in rats. Behav Brain Res. 2009 Jan 30; 197(1):41-4.
    View in: PubMed
    Score: 0.006
  22. Acid ceramidase inhibition: a novel target for cancer therapy. Front Biosci. 2008 Jan 01; 13:2293-8.
    View in: PubMed
    Score: 0.005
  23. Simultaneous quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. Methods. 2006 Jun; 39(2):82-91.
    View in: PubMed
    Score: 0.005
  24. Potent antitumor activity of a novel cationic pyridinium-ceramide alone or in combination with gemcitabine against human head and neck squamous cell carcinomas in vitro and in vivo. J Pharmacol Exp Ther. 2006 Jun; 317(3):1188-99.
    View in: PubMed
    Score: 0.005
  25. Ceramide 1-phosphate acts as a positive allosteric activator of group IVA cytosolic phospholipase A2 alpha and enhances the interaction of the enzyme with phosphatidylcholine. J Biol Chem. 2005 May 06; 280(18):17601-7.
    View in: PubMed
    Score: 0.004
  26. Positively charged ceramide is a potent inducer of mitochondrial permeabilization. J Biol Chem. 2005 Apr 22; 280(16):16096-105.
    View in: PubMed
    Score: 0.004
  27. Cloning and characterization of a mouse endoplasmic reticulum alkaline ceramidase: an enzyme that preferentially regulates metabolism of very long chain ceramides. J Biol Chem. 2003 Aug 15; 278(33):31184-91.
    View in: PubMed
    Score: 0.004
  28. Substrate specificity of rat brain ceramidase. J Lipid Res. 2002 Jan; 43(1):141-8.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.